MeSH tree: C23.550.470.790.250
A treatment that involves genetically modifying the body's own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type of blood cancer, results showed Monday.
Jun 5, 2023
0
37
Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric antigen receptor (CAR) T cell therapy axicabtagene ciloleucel (axi-cel) when compared ...
Jun 5, 2023
0
58
The U.S. Food and Drug Administration has granted accelerated approval for Genmab's Epkinly (epcoritamab-bysp) for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), including DLBCL arising from indolent lymphoma, ...
May 23, 2023
0
42
Indiana University Melvin and Bren Simon Comprehensive Cancer Center served as the lead site for a promising first-in-human clinical trial for patients with relapsed multiple myeloma. Patients treated with higher doses of ...
Apr 17, 2023
0
53
The CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouraging response rates and disease control rates in patients with metastatic clear cell renal cell carcinoma (ccRCC), ...
Apr 17, 2023
0
45
Clinical data increasingly has shown that patients with low vitamin D levels have a greater chance of COVID-19 infection—and severe disease and death. Now, research led by scientists from Lankenau Institute for Medical Research ...
Apr 13, 2023
0
644
Why do some people experience few symptoms, while others become seriously ill, when infected with a virus such as the flu or COVID-19? Ph.D. researcher Laura Van Eyndhoven sought to answer this question by looking at cells ...
Mar 9, 2023
0
35
Mass General researchers have discovered a novel molecular mechanism responsible for the most common forms of acquired hydrocephalus, potentially opening the door to the first-ever nonsurgical treatment for a life-threatening ...
Mar 8, 2023
0
70
A team of medical researchers at Stanford University, working with a colleague from the Institute of Biomedical Sciences in Taiwan, has discovered a possible way to prevent or treat lung damage associated with long COVID. ...
For patients with pretreated relapsed and refractory multiple myeloma, idecabtagene vicleucel (ide-cel), a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy, prolongs progression-free survival and ...
Feb 10, 2023
0
45
